Loading…
StockAnalyzerLoading…
News and SEC filings for 30 days explain why the price moved. ★ — the news is about the company itself; ▲▼ — events found by keywords in the headline, not a signal.
| ★ 30.10.2026 15:46 UTC | EXEL Q3 Earnings Beat Estimates on Strong Cabometyx Sales ▲ Earnings beat | Zacks |
| ★ 30.10.2026 15:09 UTC | ABBV Beats on Q3 Earnings & Sales, Stock Rises on Raised '26 EPS View | Zacks |
| 30.10.2026 14:02 UTC | ALNY Stock Down 25% Despite Q3 Earnings Beat on Demand Growth Concerns | Zacks |
| 28.10.2026 16:11 UTC | BIIB's Q3 Earnings Beat, New Drugs Aid Sales, '26 EPS View Tightened | Zacks |
| 28.10.2026 06:00 UTC | Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma | GlobeNewswire |
| 27.10.2026 14:49 UTC | NVS' Q3 Earnings Top Estimates on Strong Key Drug Sales, Revenues Miss ▲ Earnings beat | Zacks |
| 27.10.2026 14:32 UTC | Buy, Hold or Sell ABBV Stock? Key Tips Ahead of Q3 Earnings | Zacks |
| 27.10.2026 06:00 UTC | Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories | GlobeNewswire |
No SEC filings in 30 days (US companies only).